1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Finland >
  5. Targovax AS Acquires Oncos Therapeutics Oy

Add-on Acquisition • Life Science

Targovax AS Acquires Oncos Therapeutics Oy

On June 18, 2015, Targovax AS acquired life science company Oncos Therapeutics Oy

Acquisition Context
  • This is Targovax AS’s 1st transaction in the Life Science sector.
  • This is Targovax AS’s 1st transaction in Finland.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary
Date June 18, 2015
Target Oncos Therapeutics Oy
Sector Life Science
Buyer(s) Targovax AS
Deal Type Add-on Acquisition
Advisor(s) Guggenheim Securities (Financial)

Target Company

Oncos Therapeutics Oy

Helsinki, Finland
Oncos Therapeutics Oy is a biotechnology company focused on the development and commercialization of targeted cancer immunotherapy.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Targovax AS

Lysaker, Norway
Category Company
Founded 2010
Sector Life Science
DESCRIPTION

Targovax AS is a biotechnology company, dedicated to the design and development of immunotherapy vaccines for patients with RAS-mutated cancers.

Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Add-on Acquisition 1 of 1
Country: Finland 1 of 1
Year: 2015 1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Finland M&A - 2015 M&A

Mergr

Solution for

Product

Company

Legal